The strategic assessment of Hologic, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market. SECTION I: EXECUTIVE SUMMARY SECTION II: BUSINESS ORGANIZATION  - History of the company’s diagnostic imaging business evolution, which is important to    understanding the corporate culture, management mentality and strategies.  - Recent acquisitions, divestitures and major organizational changes.   SECTION III: FACILITIES AND EMPLOYEES   SECTION IV: TECHNOLOGICAL KNOW-HOW   SECTION V: PRODUCT PORTFOLIO  - Placements and installed base of major systems in the U.S. and abroad, by modality.  - Review of major product lines.   SECTION VI: MARKETING TACTICS SECTION VII: FINANCIAL ANALYSIS  - Estimated sales and operating profit by division, geographic region and product line.  - Five-year sales and operating profit performance. SECTION VIII: R&D EXPENDITURES AND MAJOR PROGRAMS SECTION IX: COLLABORATIVE ARRANGEMENTS  - Joint ventures, distribution, O.E.M. and licensing partners, both... Research Beam Model: Research Beam Product ID: 302018 0 USD New
2015 Hologic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015 Hologic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

 
 
 

The strategic assessment of Hologic, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.


SECTION I: EXECUTIVE SUMMARY


SECTION II: BUSINESS ORGANIZATION

 - History of the company’s diagnostic imaging business evolution, which is important to

   understanding the corporate culture, management mentality and strategies.

 - Recent acquisitions, divestitures and major organizational changes.

 

SECTION III: FACILITIES AND EMPLOYEES  


SECTION IV: TECHNOLOGICAL KNOW-HOW

 

SECTION V: PRODUCT PORTFOLIO

 - Placements and installed base of major systems in the U.S. and abroad, by modality.

 - Review of major product lines.  


SECTION VI: MARKETING TACTICS



SECTION VII: FINANCIAL ANALYSIS

 - Estimated sales and operating profit by division, geographic region and product line.

 - Five-year sales and operating profit performance.


SECTION VIII: R&D EXPENDITURES AND MAJOR PROGRAMS



SECTION IX: COLLABORATIVE ARRANGEMENTS

 - Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.

 - Terms of collaborative agreements and specific products involved.


SECTION X: STRATEGIC DIRECTION


List of Tables


Hologic Sales and Operating Profit Growth


Hologic Sales by Product Line/Business


Hologic Sales Growth by Product Line/Business


Hologic Operating Profit by Product Line


Hologic Operating Profit Growth by Product Line


Hologic Sales by Geographic Region


Hologic Sales Product Growth by Geographic Region


Contains 49 pages and 7 tables